GHA
IRWD icon

GW Henssler & Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History

GW Henssler & Associates’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,828
Closed -$96.7K – 207
2024
Q2 		$96.7K Buy
14,828
+1,007
+7% +$7.12K 0.01% 165
2024
Q1 		$120K Hold
13,821
– – 0.01% 169
2023
Q4 		$158K Sell
13,821
-5,500
-28% -$54.4K 0.01% 155
2023
Q3 		$186K Buy
+19,321
New +$189K 0.01% 198

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GW Henssler & Associates's IRWD Position: Q3 2024 in Review

GW Henssler & Associates sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 14,828 shares — an estimated $96.7K sold.

GW Henssler & Associates first reported a position in IRWD in Q3 2023 and held it in 4 quarters. The position peaked at $186K in Q3 2023. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • GW Henssler & Associates reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • GW Henssler & Associates sold 14,828 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $96.7K.
  • GW Henssler & Associates first reported a position in Ironwood Pharmaceuticals in Q3 2023 and held it in 4 quarters.
  • GW Henssler & Associates's Ironwood Pharmaceuticals position peaked at $186K in Q3 2023.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on GW Henssler & Associates's 13F filing for Q3 2024, filed 25 Oct 2024.